Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. The company is known for its innovative research and development capabilities, focusing on areas such as ophthalmology, oncology, immunology, and infectious diseases. Regeneron has a strong commitment to scientific excellence and has developed several FDA-approved treatments that have made significant impacts on patient care.

In terms of sustainability, Regeneron is actively working to reduce its environmental impact. The company has set ambitious goals to decrease its carbon footprint and improve energy efficiency across its operations. Regeneron has been recognized for its efforts in sustainability, receiving accolades for its green building initiatives and waste reduction programs. However, detailed ESG reports and specific carbon footprint calculations are not extensively available in the public domain.

Regeneron is committed to ethical business practices and transparency, ensuring that its operations align with high standards of corporate responsibility. The company is also involved in various community engagement programs, aiming to make a positive impact beyond its core business activities.